Pancreatic Cancer Research

ResearcherHenan UniversityActive in the last 2 years

Lianyuan Tao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3658-5103; OpenAlex author ID A5086689827. Sources: OpenAlex.

Their work

Papers
15 (first author 4, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
16
Papers, trials and grants by year

2016: 3 papers · 2017: 2 papers · 2018: 2 papers · 2019: 3 papers · 2020: none · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers

Papers 15

  1. SPP1 + macrophages facilitate pancreatic cancer progression via ITGB6-mediated interactions: evidence from integrated multi-omics analysis and experimental val… Last author DOI 10.1007/s12026-025-09666-x↗
  2. Multi-omics integration and machine learning uncover molecular basal-like subtype of pancreatic cancer and implicate A2ML1 in promoting tumor epithelial-mesenc… Last author DOI 10.1186/s12967-025-06711-z↗
  3. Expression, oncological and immunological characterizations of BZW1/2 in pancreatic adenocarcinoma. Co-author DOI 10.3389/fgene.2022.1002673↗
  4. Integrated proteomics and phosphoproteomics reveal perturbed regulative pathways in pancreatic ductal adenocarcinoma. Co-author DOI 10.1039/d0mo00125b↗
  5. Portal Venous Circulating Tumor Cells Undergoing Epithelial-Mesenchymal Transition Exhibit Distinct Clinical Significance in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2021.757307↗
  6. Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer. Co-author DOI 10.1007/s11306-019-1550-1↗
  7. Postoperative metastasis prediction based on portal vein circulating tumor cells detected by flow cytometry in periampullary or pancreatic cancer. Co-author DOI 10.2147/cmar.s210332↗
  8. Serum Derived Exosomes From Pancreatic Cancer Patients Promoted Metastasis: An iTRAQ-Based Proteomic Analysis. First author DOI 10.2147/ott.s229494↗
  9. The prognostic value of B7-H4 in pancreatic cancer: Systematic review and meta-analysis. First author DOI 10.1097/md.0000000000010088↗
  10. G-CSF associates with neurogenesis and predicts prognosis and sensitivity to chemotherapy in pancreatic ductal adenocarcinoma. First author DOI 10.2147/cmar.s165226↗
  11. Surgical resection of a primary tumor improves survival of metastatic pancreatic cancer: a population-based study. Co-author DOI 10.2147/cmar.s145722↗
  12. Prognostic role of lymphocyte to monocyte ratio for patients with pancreatic cancer: a systematic review and meta-analysis. First author DOI 10.2147/ott.s142022↗
  13. Neutrophils assist the metastasis of circulating tumor cells in pancreatic ductal adenocarcinoma: A new hypothesis and a new predictor for distant metastasis. Co-author DOI 10.1097/md.0000000000004932↗
  14. Prognostic significance of K-ras mutations in pancreatic cancer: a meta-analysis. Co-author DOI 10.1186/s12957-016-0888-3↗
  15. Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict lymph node metastasis in patients with pancreatic ductal adenocarcinoma (PDAC). Co-author DOI 10.18632/oncotarget.11031↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Deyu Li · 4 shared papers, 2019–2025 · strength 0.94
  2. Jiachen Ge · 3 shared papers, 2022–2025 · strength 0.84
  3. Dianrong Xiu · 9 shared papers, 2016–2021 · strength 0.84
  4. Chunhui Yuan · 8 shared papers, 2016–2019 · strength 0.71
  5. Lingfu Zhang · 8 shared papers, 2016–2019 · strength 0.70
  6. Bin Jiang · 5 shared papers, 2016–2018 · strength 0.36
  7. Lijun Zhong · 2 shared papers, 2019–2021 · strength 0.26
  8. Juntuo Zhou · 2 shared papers, 2019–2021 · strength 0.26
  9. Dianrong Xiu · 2 shared papers, 2019 · strength 0.23
  10. Yujin Pan · 1 shared paper, 2021 · strength 0.13
  11. Dongxiao Li · 1 shared paper, 2021 · strength 0.13
  12. Puxian Tang · 1 shared paper, 2019 · strength 0.12
  13. Xin Chen · 1 shared paper, 2018 · strength 0.12
  14. Wendi Li · 1 shared paper, 2017 · strength 0.10
  15. Chunhui Yuan · 1 shared paper, 2017 · strength 0.09
  16. Jun Zhan · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.